Practical Bayesian adaptive randomisation in clinical trials

European Journal of Cancer

Volumn 43, Issue 5, 2007, Pages 859-866

  Thall, Peter F ^a   Wathen, J Kyle ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Adaptive design; Bayesian design; Clinical trials; Medical ethics; Randomisation

Indexed keywords

DOCETAXEL; GEMCITABINE;

ADVANCED CANCER; ARTICLE; BAYES THEOREM; CANCER CHEMOTHERAPY; COMBINATION CHEMOTHERAPY; HUMAN; HYPOTHESIS; MEDICAL DECISION MAKING; MONOTHERAPY; PRIORITY JOURNAL; RANDOMIZATION; SCIENTIFIC LITERATURE; SOFT TISSUE SARCOMA; STATISTICAL ANALYSIS; TREATMENT PLANNING;

BAYES THEOREM; HUMANS; NORMAL DISTRIBUTION; PROBABILITY; RANDOMIZED CONTROLLED TRIALS;

EID: 33847666453     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.01.006     Document Type: Article

References (30)

1. Fisher R.A. The design of experiments (1935), Oliver and Boyd, Edinburgh
2. Zelen M. The randomization and stratification of patients to clinical trials. J Chronic Diseases 27 (1974) 365-375
3. Hill A.B. Medical ethics and controlled trials. Br Med J 1 (1963) 1043-1049
4. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 317 (1987) 141-145
5. Royall R.M. Ethics and statistics in randomized clinical trials (with discussion). Stat Sci 6 (1991) 52-88
6. Emanuel E.J., and Patterson W.B. Ethics of randomized clinical trials. J Clin Oncol 48 (1998) 6-29
7. Ashcroft R. Equipoise, knowledge and ethics in clinical research and practice. Bioethics 13 (1999) 314-326
8. Cox D.R. Regression models and life tables (with discussion). J Roy Stat Soc B 34 (1972) 187-220
9. Estey E.H., and Thall P.F. New designs for phase 2 clinical trials. Blood 102 (2003) 442-448
10. Gail M.H., Wieand S., and Piantadosi S. Biased estimates of treatment effect in randomized experiments with nonlinear regressions and omitted covariates. Biometrika 71 (1984) 431-444
11. Localio A.R., Berlin J.A., Ten Have T.R., and Kimmel S.E. Adjustments for center in multicenter studies: an overview. Ann Internal Med 135 (2001) 112-123
12. Pocock S.J. Clinical trials: a practical approach (1984), Wiley, New York
13. Piantadosi S. Clinical trials (1997), Wiley, New York
14. Rosenberger W.F., and Lachin J.M. Randomization in clinical trials: theory and practice (2002), Wiley, New York
15. Gelman A., Carlin J.B., Stern H.S.A., and Rubin D.B. Bayesian data analysis. 2nd ed. (2004), Chapman and Hall/CRC, Boca Raton
16. Smith A.F.M., and Gelfand A.E. Bayesian statistics without tears: a sampling resampling perspective. Am Statist 46 (1992) 84-88
17. Spiegelhalter D., Thomas A., Best N., and Gilks W. BUGS: Bayesian inference using Gibbs sampling, Version 0.50 (1995), MRC Biostatistics Unit, Cambridge, UK
18. In: Berry D.A., and Stangl D.K. (Eds). Bayesian biostatistics (1996), Marcell Dekker, New York
19. Berry D.A. A case for Bayesianism in clinical trials (with discussion). Stat Med 12 (1993) 1377-1404
20. Spiegelhalter D.J., David J., Abrams K.R., and Myles J.P. Bayesian approaches to clinical trials and health-care evaluation (2004), Wiley, New York
21. Zelen M. A new design for randomized clinical trials. N Engl J Med 300 (1979) 1242-1246
22. Karrison T.G., Huo D., and Chappell R. A group sequential, response-adaptive design for randomized clinical trials. Contr Clin Trials 24 (2003) 506-522
23. Hu F., and Rosenberger W.F. Response adaptive randomization (2006), Wiley, Hoboken
24. Berry D.A., and Eick S.G. Adaptive assignment versus balanced randomization in clinical trials: a decision analysis. Stat Med 14 (1995) 231-246
25. Cheung Y.K., Inoue L.Y.T., Wathen J.K., and Thall P.F. Continuous Bayesian adaptive randomization based on event times with covariates. Stat Med 25 (2006) 55-70
26. Bartlett R.H., Roloff D.W., Cornell R.G., Andrews A.F., Dillon P.W., and Zwischenberger J.B. Extra-corporeal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics 76 (1985) 476-487
27. Thall P.F., Inoue L.Y.T., and Martin T. Adaptive decision making in a lymphocyte infusion trial. Biometrics 58 (2002) 560-568
28. Thall P.F., and Wathen J.K. Covariate-adjusted adaptive randomization in a sarcoma trial with multi-stage treatments. Stat Med 24 (2005) 1947-1964
29. Thompson W.R. On the likelihood that one unknown probability exceeds another in view of the evidence of two samples. Biometrika 25 (1933) 285-294
30. Maki R.G., Hensley M.L., Wathen J.K., et al. A SARC multicenter phase III study of gemcitabine vs. gemcitabine and docetaxel in patients with metastatic soft tissue sarcomas. J Clin Oncol 24 18S (2006) 9514